18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.
暂无分享,去创建一个
Paul K Marsden | Dan Liu | Anastasia Chalkidou | John D Fenwick | P. Marsden | D. Landau | J. Fenwick | A. Chalkidou | David B Landau | Dan Liu | D. Liu
[1] Sung-Cheng Huang,et al. Derivation of a Compartmental Model for Quantifying 64Cu-DOTA-RGD Kinetics in Tumor-Bearing Mice , 2009, Journal of Nuclear Medicine.
[2] R. Jain,et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.
[3] Vincent Gregoire,et al. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.
[4] G. Watkins,et al. Kinetic Analysis of 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy , 2009, Journal of Nuclear Medicine.
[5] T. Cloughesy,et al. 18 F-fluorothymidine kinetics of malignant brain tumors , 2007 .
[6] K. Jingu,et al. Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP , 2010, BMC Cancer.
[7] C Cobelli,et al. Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. , 2001, American journal of physiology. Endocrinology and metabolism.
[8] Ewert Bengtsson,et al. Noise correlation in PET, CT, SPECT and PET/CT data evaluated using autocorrelation function: a phantom study on data, reconstructed using FBP and OSEM , 2005, BMC Medical Imaging.
[9] Mark Muzi,et al. Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Hubert Vesselle,et al. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine. , 2007, Seminars in nuclear medicine.
[11] D Eidelberg,et al. Quantitative brain FDG/PET studies using dynamic aortic imaging. , 1994, Physics in medicine and biology.
[12] Eric O. Aboagye,et al. Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[13] D. Feng,et al. Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] C. Cobelli,et al. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.
[15] Søren M Bentzen,et al. Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.
[16] M A Konerding,et al. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon , 2001, British Journal of Cancer.
[17] R. Boellaard,et al. Reproducibility of quantitative 18F-3′-deoxy-3′-fluorothymidine measurements using positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[18] D. Feng,et al. Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. , 1993, International journal of bio-medical computing.
[19] S. Yao,et al. The Role of Human Nucleoside Transporters in Uptake of 3′-Deoxy-3′-fluorothymidine , 2008, Molecular Pharmacology.
[20] Kewei Chen,et al. An input function estimation method for FDG-PET human brain studies. , 2007, Nuclear medicine and biology.
[21] W. Oyen,et al. 18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients , 2007, Journal of Nuclear Medicine.
[22] John L. Humm,et al. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.
[23] Sung-Cheng Huang,et al. 18F-fluorothymidine kinetics of malignant brain tumors , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[24] D. Visvikis,et al. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[25] R. Boellaard,et al. Reproducibility of quantitative 18 F-3 ′-deoxy-3 ′-fluorothymidine measurements using positron emission tomography , 2009 .
[26] S S Gambhir,et al. A fast nonlinear method for parametric imaging of myocardial perfusion by dynamic (13)N-ammonia PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[28] Mark Muzi,et al. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] P. Marsden,et al. Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. , 2012, European journal of cancer.
[30] R. Jain,et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.
[31] L. Wiens,et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] Adrian E. Raftery,et al. How Many Clusters? Which Clustering Method? Answers Via Model-Based Cluster Analysis , 1998, Comput. J..
[33] Adrian C. Shieh,et al. Biomechanical Forces Shape the Tumor Microenvironment , 2011, Annals of Biomedical Engineering.
[34] Otto Muzik,et al. A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[35] N. Laird,et al. Meta-analysis in clinical trials revisited. , 2015, Contemporary clinical trials.
[36] Stefan Eberl,et al. Evaluation of two population-based input functions for quantitative neurological FDG PET studies , 1997, European Journal of Nuclear Medicine.
[37] J. Sherley,et al. Regulation of human thymidine kinase during the cell cycle. , 1988, The Journal of biological chemistry.
[38] Fang-Xiang Wu,et al. Genetic weighted k-means algorithm for clustering large-scale gene expression data , 2008, BMC Bioinformatics.
[39] David R. Anderson,et al. Multimodel Inference , 2004 .
[40] Paul Marsden,et al. Estimation of input functions from dynamic [18F]FLT PET studies of the head and neck with correction for partial volume effects , 2013, EJNMMI Research.
[41] G A Ojemann,et al. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[43] Jeih-San Liow,et al. Image-Derived Input Function for Human Brain Using High Resolution PET Imaging with [11C](R)-rolipram and [11C]PBR28 , 2011, PloS one.
[44] Johan Bussink,et al. PET–CT for radiotherapy treatment planning and response monitoring in solid tumors , 2011, Nature Reviews Clinical Oncology.
[45] Michael Horn,et al. Tumour size measurement in a mouse model using high resolution MRI , 2012, BMC Medical Imaging.
[46] Torsten Mattfeldt,et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] J. Schwartz,et al. The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells. , 2011, Nuclear medicine and biology.
[48] C C Ling,et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.
[49] D Feng,et al. A computer simulation study on the effects of input function measurement noise in tracer kinetic modeling with positron emission tomography (PET). , 1993, Computers in biology and medicine.
[50] H. Vesselle,et al. Tumor 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors , 2011, The Journal of Nuclear Medicine.
[51] M. Bal,et al. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[52] Tania B. Huedo-Medina,et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? , 2006, Psychological methods.
[53] G. Glatting,et al. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[54] Mark Muzi,et al. In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[55] J. Rodgers,et al. Thirteen ways to look at the correlation coefficient , 1988 .
[56] K. Krohn,et al. Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells , 2010, The Journal of Nuclear Medicine.
[57] R. Dennis Cook,et al. Cross-Validation of Regression Models , 1984 .
[58] I. Buvat,et al. Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.
[59] K. Herholz,et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.
[60] Kristian Pietras,et al. High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.
[61] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[62] A. Shinomiya,et al. Evaluation of 3′-deoxy-3′-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[63] Eric P. Visser,et al. A Curve-Fitting Approach to Estimate the Arterial Plasma Input Function for the Assessment of Glucose Metabolic Rate and Response to Treatment , 2009, Journal of Nuclear Medicine.
[64] Y. Nishiyama,et al. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[65] Sung-Cheng Huang,et al. Evaluation of an Input Function Model that Incorporates the Injection Schedule in FDG-PET Studies , 2006, 2006 IEEE Nuclear Science Symposium Conference Record.
[66] R K Jain,et al. Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.
[67] H. Vesselle,et al. A SepPak unit for batch processing serial blood plasma samples for PET , 2007 .
[68] D. Mankoff,et al. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[69] S. Huang,et al. The effects of measurement errors in the plasma radioactivity curve on parameter estimation in positron emission tomography. , 1991, Physics in medicine and biology.
[70] Gunilla Borgefors. Theory and applications of image analysis II : selected papers from the 9th Scandinavian Conference on Image Analysis , 1995 .
[71] Mark Muzi,et al. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[72] W. G. Cochran. The $\chi^2$ Test of Goodness of Fit , 1952 .